Skip to content

SRTA SRTA Fair Value Adjustment Of Warrants

Fair Value Adjustment Of Warrants at other companies

Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
-$232K-135%

Other financials

Income statement

See full
Revenue$67.4M+87.4%
Gross profit$14.1M+100%
Operating income-$3.0M+47.7%
Net income$2.2M+162%
EPS (diluted)$0.03+175%

Balance sheet

See full
Cash & equivalents$59.0M+65.3%
Total debt$4.5M-50.7%
Total equity$285.7M+30.0%
Total assets$327.6M+30.8%

Cash flow

See full
Operating cash flow$3.9M+1,679%
CapEx$5.2M+98.1%
Free cash flow-$1.3M+54.8%

Valuation

See full
Market cap$463.78M+24.0%
Enterprise value$409.26M
P/E8.9×
P/S1.8×

Profitability

See full
Gross margin21.7%+1.3pp
Operating margin-7.8%-2.8pp
Net margin21%+13.6pp
FCF margin-22.4%+1,712pp

Returns & leverage

See full
Return on equity15.6%+10.0pp
Debt / equity0.0×
Current ratio5.9×-1.0×

Where this comes from

Reported directly by SRTA in its filing.

Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.

The official record: SRTA’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about SRTA's fair value adjustment of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SRTA's fair value adjustment of warrants?
SRTA (SRTA) reported fair value adjustment of warrants of -$1.46M in Q1 2026.
How has SRTA's fair value adjustment of warrants changed year-over-year?
SRTA's fair value adjustment of warrants increased by 47.0% year-over-year, from -$2.75M to -$1.46M.
What is the long-term trend for SRTA's fair value adjustment of warrants?
Over 3 years (2021 to 2025), SRTA's fair value adjustment of warrants has grown at a -16.8% compound annual growth rate (CAGR), from $7.42M to -$4.28M.
What does fair value adjustment of warrants mean?
This metric represents the non-cash periodic adjustment to the carrying value of warrant liabilities based on changes in their estimated fair value. Fluctuations in this value reflect changes in market conditions, stock price volatility, or the remaining term of the warrants. It is a non-operating item that impacts net income without affecting immediate cash flow.